{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:06:44Z","timestamp":1789495604613,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402711"],"award-info":[{"award-number":["82402711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372701"],"award-info":[{"award-number":["82372701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82293662"],"award-info":[{"award-number":["82293662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Leading Talent Program of Eastern Talent Plan"},{"name":"Leading Talents in Health Care of Shanghai Municipal Health Commission","award":["2022LJ020"],"award-info":[{"award-number":["2022LJ020"]}]},{"name":"Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics","award":["20dz2260900"],"award-info":[{"award-number":["20dz2260900"]}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanya Science and Technology Special Fund","award":["2022KJCX38"],"award-info":[{"award-number":["2022KJCX38"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatoblastoma (HB) is the most common pediatric liver malignancy with an increasing incidence. However, the functional roles of 3D chromatin organization, epigenetic regulatory factors, and transcriptional reprogramming in HB pathogenesis remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\u200bIntegrated multi-omics analyses of HB and matched non-tumor tissues were performed, including Hi-C, H3K27ac CUT&amp;Tag, ATAC-seq, and RNA-seq, to construct high-resolution 3D epigenomic maps and identify genes interacting with HB-specific super-enhancers (SEs). Functional assays of identified targets were conducted in cell lines and animal models. The regulatory mechanisms of SEs and upstream transcription factors (TFs) were investigated using CRISPRi-dCas9, 3C-qPCR, ChIP-qPCR, and luciferase reporter assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comprehensive analysis identified TRIB2 as an HB-specific SE-associated oncogene. Functionally, TRIB2 promoted cell proliferation and accelerated tumor growth both in vitro and in vivo. Patients with high TRIB2 expression exhibited advanced PRETEXT stage and metastasis. Mechanistically, TCF3 directly bound to both the TRIB2-SE and its promoter, promoting TRIB2 overexpression. Moreover, TRIB2 conferred resistance to ferroptosis by disrupting KEAP1-mediated ubiquitination of NRF2, thereby stabilizing NRF2 protein and enhancing antioxidant responses. The TCF3-TRIB2-NRF2 axis showed significant co-expression in HB tissues, effectively distinguished HB from normal liver tissues, and was associated with poorer overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings reveal that TCF3 and SE mediate TRIB2 overexpression to inhibit ferroptosis via the KEAP1-NRF2 pathway and drive HB pathogenesis, providing potential diagnostic and prognostic markers for HB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03587-1","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:13:44Z","timestamp":1767028424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation"],"prefix":"10.1186","volume":"44","author":[{"given":"Han","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianshu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cizhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"1","key":"3587_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41572-025-00620-7","volume":"11","author":"L Pio","year":"2025","unstructured":"Pio L, O\u2019Neill AF, Woodley H, Murphy AJ, Tiao G, Franchi-Abella S, et al. Hepatoblastoma Nat Rev Dis Primers. 2025;11(1):36.","journal-title":"Hepatoblastoma Nat Rev Dis Primers"},{"issue":"1","key":"3587_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin P, Chen Y, Trevino LR, Sarabia SF, Hampton OA, Patel K, et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 2017;65(1):104\u201321.","journal-title":"Hepatology"},{"issue":"1","key":"3587_CR3","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","volume":"12","author":"G Nagae","year":"2021","unstructured":"Nagae G, Yamamoto S, Fujita M, Fujita T, Nonaka A, Umeda T, et al. Genetic and epigenetic basis of hepatoblastoma diversity. Nat Commun. 2021;12(1):5423.","journal-title":"Nat Commun"},{"issue":"7696","key":"3587_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","volume":"555","author":"SN Grobner","year":"2018","unstructured":"Grobner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, et al. The landscape of genomic alterations across childhood cancers. Nature. 2018;555(7696):321\u20137.","journal-title":"Nature"},{"issue":"1","key":"3587_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-0040-1722645","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Solinas A, Cairo S, Evert M, Chen X, Calvisi DF. Molecular mechanisms of hepatoblastoma. Semin Liver Dis. 2021;41(1):28\u201341.","journal-title":"Semin Liver Dis"},{"issue":"4","key":"3587_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jhep.2023.05.031","volume":"79","author":"A Claveria-Cabello","year":"2023","unstructured":"Claveria-Cabello A, Herranz JM, Latasa MU, Arechederra M, Uriarte I, Pineda-Lucena A, et al. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma. J Hepatol. 2023;79(4):989\u20131005.","journal-title":"J Hepatol"},{"issue":"1","key":"3587_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2018.09.002","volume":"175","author":"L Vian","year":"2018","unstructured":"Vian L, Pekowska A, Rao SSP, Kieffer-Kwon KR, Jung S, Baranello L, et al. The energetics and physiological impact of cohesin extrusion. Cell. 2018;175(1):292\u20134.","journal-title":"Cell"},{"issue":"12","key":"3587_CR8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10(12):1213\u20138.","journal-title":"Nat Methods"},{"issue":"1","key":"3587_CR9","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1038\/s41467-019-12079-8","volume":"10","author":"SK Rhie","year":"2019","unstructured":"Rhie SK, Perez AA, Lay FD, Schreiner S, Shi J, Polin J, et al. A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome. Nat Commun. 2019;10(1):4154.","journal-title":"Nat Commun"},{"issue":"5","key":"3587_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"2","key":"3587_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A regulated cell death nexus linking Metabolism, redox Biology, and disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"1","key":"3587_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9(1):271.","journal-title":"Signal Transduct Target Ther"},{"key":"3587_CR13","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.","journal-title":"Redox Biol"},{"key":"3587_CR14","doi-asserted-by":"publisher","first-page":"102726","DOI":"10.1016\/j.redox.2023.102726","volume":"63","author":"S Adinolfi","year":"2023","unstructured":"Adinolfi S, Patinen T, Jawahar Deen A, Pitkanen S, Harkonen J, Kansanen E, et al. The KEAP1-NRF2 pathway: targets for therapy and role in cancer. Redox Biol. 2023;63:102726.","journal-title":"Redox Biol"},{"key":"3587_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mce.2014.12.013","volume":"401","author":"J Vriend","year":"2015","unstructured":"Vriend J, Reiter RJ. The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome. Mol Cell Endocrinol. 2015;401:213\u201320.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"3587_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934\u201347.","journal-title":"Cell"},{"issue":"4","key":"3587_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","volume":"3","author":"S Sengupta","year":"2017","unstructured":"Sengupta S, George RE. Super-Enhancer-Driven transcriptional dependencies in cancer. Trends Cancer. 2017;3(4):269\u201381.","journal-title":"Trends Cancer"},{"issue":"1","key":"3587_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-019-0757-y","volume":"12","author":"Y Jia","year":"2019","unstructured":"Jia Y, Chng WJ, Zhou J. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. J Hematol Oncol. 2019;12(1):77.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3587_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13046-024-02996-y","volume":"43","author":"H Cai","year":"2024","unstructured":"Cai H, Liang J, Jiang Y, Wang Z, Li H, Wang W, et al. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2024;43(1):69.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3587_CR20","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/s41467-018-06081-9","volume":"9","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Jiang YY, Xie JJ, Mayakonda A, Hazawa M, Chen L, et al. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat Commun. 2018;9(1):3619.","journal-title":"Nat Commun"},{"issue":"3","key":"3587_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.devcel.2015.10.019","volume":"35","author":"LH Wang","year":"2015","unstructured":"Wang LH, Baker NE, Proteins E, Proteins ID. Helix-Loop-Helix partners in development and disease. Dev Cell. 2015;35(3):269\u201380.","journal-title":"Dev Cell"},{"issue":"4","key":"3587_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.tcb.2016.11.002","volume":"27","author":"PA Eyers","year":"2017","unstructured":"Eyers PA, Keeshan K, Kannan N. Tribbles in the 21st century: the evolving roles of tribbles pseudokinases in biology and disease. Trends Cell Biol. 2017;27(4):284\u201398.","journal-title":"Trends Cell Biol"},{"issue":"23","key":"3587_CR23","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1182\/blood-2009-10-247361","volume":"116","author":"K Keeshan","year":"2010","unstructured":"Keeshan K, Bailis W, Dedhia PH, Vega ME, Shestova O, Xu L, et al. Transformation by tribbles homolog 2 (Trib2) requires both the Trib2 kinase domain and COP1 binding. Blood. 2010;116(23):4948\u201357.","journal-title":"Blood"},{"issue":"1","key":"3587_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12964-021-00725-y","volume":"19","author":"Y Fang","year":"2021","unstructured":"Fang Y, Zekiy AO, Ghaedrahmati F, Timoshin A, Farzaneh M, Anbiyaiee A, et al. Tribbles homolog 2 (Trib2), a Pseudo serine\/threonine kinase in tumorigenesis and stem cell fate decisions. Cell Commun Signal. 2021;19(1):41.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3587_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12964-024-01985-0","volume":"23","author":"W Zhang","year":"2025","unstructured":"Zhang W, Li M, Zhang M, Yan G, Tang C. The role of tribbles homolog 2 in cell proliferation. Cell Commun Signal. 2025;23(1):5.","journal-title":"Cell Commun Signal"},{"issue":"7","key":"3587_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.14348\/molcells.2021.0030","volume":"44","author":"DK Kim","year":"2021","unstructured":"Kim DK, Kim YN, Kim YE, Lee SY, Shin MJ, Do EK, et al. TRIB2 stimulates cancer Stem-Like properties through activating the AKT-GSK3beta-beta-Catenin signaling axis. Mol Cells. 2021;44(7):481\u201392.","journal-title":"Mol Cells"},{"issue":"7","key":"3587_CR27","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SS Rao","year":"2014","unstructured":"Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A 3D map of the human genome at Kilobase resolution reveals principles of chromatin looping. Cell. 2014;159(7):1665\u201380.","journal-title":"Cell"},{"issue":"4","key":"3587_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357\u20139.","journal-title":"Nat Methods"},{"issue":"1","key":"3587_CR29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1186\/1471-2164-15-752","volume":"15","author":"T Lesluyes","year":"2014","unstructured":"Lesluyes T, Johnson J, Machanick P, Bailey TL. Differential motif enrichment analysis of paired ChIP-seq experiments. BMC Genomics. 2014;15(1):752.","journal-title":"BMC Genomics"},{"key":"3587_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13059-015-0831-x","volume":"16","author":"N Servant","year":"2015","unstructured":"Servant N, Varoquaux N, Lajoie BR, Viara E, Chen CJ, Vert JP, et al. HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. Genome Biol. 2015;16:259.","journal-title":"Genome Biol"},{"issue":"2","key":"3587_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cell.2017.06.029","volume":"170","author":"Y Ke","year":"2017","unstructured":"Ke Y, Xu Y, Chen X, Feng S, Liu Z, Sun Y, et al. 3D chromatin structures of mature gametes and structural reprogramming during mammalian embryogenesis. Cell. 2017;170(2):367\u201381. e20.","journal-title":"Cell"},{"issue":"7559","key":"3587_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature14450","volume":"523","author":"E Crane","year":"2015","unstructured":"Crane E, Bian Q, McCord RP, Lajoie BR, Wheeler BS, Ralston EJ, et al. Condensin-driven remodelling of X chromosome topology during dosage compensation. Nature. 2015;523(7559):240\u20134.","journal-title":"Nature"},{"issue":"3","key":"3587_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cell.2017.09.043","volume":"171","author":"B Bonev","year":"2017","unstructured":"Bonev B, Mendelson Cohen N, Szabo Q, Fritsch L, Papadopoulos GL, Lubling Y, et al. Multiscale 3D genome rewiring during mouse neural development. Cell. 2017;171(3):557\u201372. e24.","journal-title":"Cell"},{"issue":"12","key":"3587_CR34","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-019-0538-0","volume":"51","author":"CP Fulco","year":"2019","unstructured":"Fulco CP, Nasser J, Jones TR, Munson G, Bergman DT, Subramanian V, et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat Genet. 2019;51(12):1664\u20139.","journal-title":"Nat Genet"},{"issue":"7","key":"3587_CR35","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/nprot.2007.243","volume":"2","author":"H Hagege","year":"2007","unstructured":"Hagege H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, et al. Quantitative analysis of chromosome conformation capture assays (3\u00a0C-qPCR). Nat Protoc. 2007;2(7):1722\u201333.","journal-title":"Nat Protoc"},{"issue":"W1","key":"3587_CR36","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet JP, Haeussler M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 2018;46(W1):W242\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"5950","key":"3587_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.1181369","volume":"326","author":"E Lieberman-Aiden","year":"2009","unstructured":"Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 2009;326(5950):289\u201393.","journal-title":"Science"},{"issue":"7398","key":"3587_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485(7398):376\u201380.","journal-title":"Nature"},{"issue":"5","key":"3587_CR39","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cell.2015.04.004","volume":"161","author":"DG Lupianez","year":"2015","unstructured":"Lupianez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E, et al. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell. 2015;161(5):1012\u201325.","journal-title":"Cell"},{"issue":"6","key":"3587_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1101\/gr.201517.115","volume":"26","author":"PC Taberlay","year":"2016","unstructured":"Taberlay PC, Achinger-Kawecka J, Lun AT, Buske FA, Sabir K, Gould CM, et al. Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations. Genome Res. 2016;26(6):719\u201331.","journal-title":"Genome Res"},{"issue":"1","key":"3587_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","volume":"17","author":"B Donati","year":"2018","unstructured":"Donati B, Lorenzini E, Ciarrocchi A. BRD4 and cancer: going beyond transcriptional regulation. Mol Cancer. 2018;17(1):164.","journal-title":"Mol Cancer"},{"issue":"3","key":"3587_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tibs.2024.12.010","volume":"50","author":"JD Hayes","year":"2025","unstructured":"Hayes JD, Dayalan Naidu S, Dinkova-Kostova AT. Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis. Trends Biochem Sci. 2025;50(3):179\u2013205.","journal-title":"Trends Biochem Sci"},{"key":"3587_CR43","doi-asserted-by":"crossref","unstructured":"Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. 2020;40(13):e00099-20.","DOI":"10.1128\/MCB.00099-20"},{"issue":"6225","key":"3587_CR44","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1259418","volume":"347","author":"E Arner","year":"2015","unstructured":"Arner E, Daub CO, Vitting-Seerup K, Andersson R, Lilje B, Drablos F, et al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science. 2015;347(6225):1010\u20134.","journal-title":"Science"},{"issue":"20","key":"3587_CR45","doi-asserted-by":"publisher","first-page":"e2407671","DOI":"10.1002\/advs.202407671","volume":"12","author":"M Ding","year":"2025","unstructured":"Ding M, Mao S, Wu H, Fang S, Zhen N, Chen T, et al. Malignant Hepatoblast-Like cells sustain stemness via IGF2-Dependent cholesterol accumulation in hepatoblastoma. Adv Sci (Weinh). 2025;12(20):e2407671.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3587_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12943-024-02033-8","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Dai W, Jin B, Jiang F, Huang H, Hou W, et al. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets. Mol Cancer. 2024;23(1):122.","journal-title":"Mol Cancer"},{"issue":"1","key":"3587_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13046-023-02763-5","volume":"42","author":"M Wang","year":"2023","unstructured":"Wang M, Chen Q, Wang S, Xie H, Liu J, Huang R, et al. Super-enhancers complexes zoom in transcription in cancer. J Exp Clin Cancer Res. 2023;42(1):183.","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"3587_CR48","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.7150\/thno.45349","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wei S, Sun WP, Teng K, Dai MM, Wang FW, et al. Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of hepatocellular carcinoma. Theranostics. 2020;10(20):9066\u201382.","journal-title":"Theranostics"},{"issue":"4","key":"3587_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41588-018-0044-9","volume":"50","author":"R Zeid","year":"2018","unstructured":"Zeid R, Lawlor MA, Poon E, Reyes JM, Fulciniti M, Lopez MA, et al. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat Genet. 2018;50(4):515\u201323.","journal-title":"Nat Genet"},{"issue":"1","key":"3587_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41420-025-02491-z","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X, Liu Y, Cao J, Wu C, Tang L, Bian W, et al. Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment. Cell Death Discov. 2025;11(1):189.","journal-title":"Cell Death Discov"},{"issue":"1","key":"3587_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41420-021-00574-1","volume":"7","author":"S Guo","year":"2021","unstructured":"Guo S, Chen Y, Xue X, Yang Y, Wang Y, Qiu S, et al. TRIB2 desensitizes ferroptosis via betaTrCP-mediated TFRC ubiquitiantion in liver cancer cells. Cell Death Discov. 2021;7(1):196.","journal-title":"Cell Death Discov"},{"issue":"13","key":"3587_CR52","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1182\/blood.2022019274","volume":"142","author":"A Schmitt","year":"2023","unstructured":"Schmitt A, Grimm M, Kreienkamp N, Junge H, Labisch J, Schuhknecht L, et al. BRD4 Inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis. Blood. 2023;142(13):1143\u201355.","journal-title":"Blood"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03587-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03587-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03587-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:02:21Z","timestamp":1767031341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03587-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3587"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03587-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures were granted by the ethics committee of Shanghai Children\u2019s Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved this manuscript for publication in the Journal of Experimental & Clinical Cancer Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}